Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors) [Phase 1, Phase 2]
Astellas-sponsored study evaluating intermittent and continuous OSI-906 with weekly paclitaxel in recurrent ovarian cancer and other solid t…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers [Phase 1, Phase 2]
Clinical trial update for Galinpepimut-S in combination with pembrolizumab in selected advanced cancers (Phase 1/2) with completed status an…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of an immunostimulatory oncolytic adenovirus has completed with posted results across pancreatic adenocarcinoma, ovarian c…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients [Phase 3]
Phase 3 trial update evaluating maintenance therapy with rucaparib after bevacizumab maintenance following carboplatin-based first-line chem…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of Pegilodecakin (LY3500518) in patients with advanced solid tumors has completed, spanning multiple indications including mel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue [NA]
The REVITALIZE trial evaluating a telehealth intervention for women with advanced ovarian cancer and PARP-inhibitor–related fatigue has comp…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a combination of T-cell infusion, Aldesleukin (IL-2), and Utomilumab in recurrent ovarian cancer has completed …
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 update describes the dose-escalation and expansion study of AROG4-01 in patients with advanced solid tumors, including mesothel…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Feasibility and Evaluation of a Self-care App to Enhance Purposeful Living [NA]
This completed study assesses the feasibility and usability of a self-care app intended to enhance purposeful living for individuals with ov…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC [EARLY_Phase 1]
This clinical trial update reports completion of an early-phase 1 randomized study (IMPACT) evaluating novel therapeutic agents in women wit…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors [Phase 1]
A Phase I trial evaluating CCT303-406 in relapsed or refractory HER2-positive solid tumors is active but not recruiting, including gastric c…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of ruxolitinib phosphate in combination with paclitaxel and carboplatin for S…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. [Phase 1, Phase 2]
Clinical trial update reporting safety, pharmacokinetics, and efficacy findings for tinostamustine in patients with advanced solid tumors, i…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy [NA]
A completed clinical trial evaluating the Halcyon 4.0 imaging system for patients receiving radiation therapy across several cancers.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer [Phase 1]
A Phase 1 study evaluating pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Systemic Inflammatory Biomarkers in Ovarian Cancer
A clinical trial investigating systemic inflammatory biomarkers in ovarian cancer has completed. The provided information does not include t…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating the P53MVA vaccine with pembrolizumab for recurrent platinum-resistant ovarian cancer, fallopian tube cancer, or pr…
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Connecting Families to Overcome Ovarian Cancer [NA]
Emory University-led trial evaluating a family-centered approach to ovarian cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer [Phase 1]
A Phase 1 crossover bioequivalence study comparing Olaparib 150 mg tablets from Lek Pharmaceuticals with Lynparza 150 mg tablets in BRCA-mut…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Association of Ex Vivo Drug Response (EVDR) and Clinical Outcome in Ovarian Cancer
An Exscientia AI-led study evaluating whether ex vivo drug response (EVDR) correlates with clinical outcomes in epithelial ovarian cancer ha…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
This document reports that an observational clinical study evaluating the imaging tracer 18F-FAPI-RGD in ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2024-09-25Clinical Trial Update: Efficacy of Biofeedback-Based Serious Game for Pain Alleviation in Middle-Aged and Older Ovarian Cancer Patients: A Randomized Controlled Trial [NA]
A completed randomized controlled trial evaluated the efficacy of a biofeedback-based serious game for pain relief in middle-aged and older …